The impact of China’s zero markup drug policy on drug costs for managing Parkinson’s disease and its complications: an interrupted time series analysis

The impact of China’s zero markup drug policy on drug costs for managing Parkinson’s disease and its complications: an interrupted time series analysis
Front Public Health. 2023 May 9;11:1159119. doi: 10.3389/fpubh.2023.1159119. eCollection 2023.ABSTRACTBACKGROUND: In April 2009, the Chinese government launched Zero Markup Drug Policy (ZMDP) to adjust medical institutions' revenue and expenditure structures.OBJECTIVE: This study evaluated the impact of implementing ZMDP (as an intervention) on the drug costs for managing Parkinson's disease (PD) and its complications from the healthcare providers' perspective.METHODS: The drug ... read more
Source: PubMedPublished on 2023-05-25By Ruilin Wang